Take-home naloxone administered in emergency settings: feasibility of intervention implementation in a cluster randomized trial
Helen A. Snooks, Jenna K. Jones, Fiona B. Bell, Jonathon R. Benger, Sarah L. Black, Simon Dixon, Adrian Edwards, Helena Emery, Bridie A. Evans, Gordon W. Fuller, Steve Goodacre, Rebecca Hoskins, Jane Hughes, Ann John, Sasha Johnston, Matthew B. Jones, Chris R. Moore

TL;DR
This study tested whether giving naloxone kits to patients in emergency settings was feasible, but found low staff and patient participation.
Contribution
The study provides insights into the challenges of implementing take-home naloxone programs in emergency healthcare settings.
Findings
Only 43.5% of clinical staff at intervention sites were trained to distribute naloxone kits.
Naloxone kits were given to only 21.7% of eligible patients.
Low recruitment and variability across sites prevented meeting criteria for a full randomized controlled trial.
Abstract
Opioids kill more people than any other class of drug. Naloxone is an opioid antagonist which can be distributed in kits for peer administration. We assessed the feasibility of implementing a Take-home Naloxone (THN) intervention in emergency settings, as part of designing a definitive randomised controlled trial (RCT). We undertook a clustered RCT on sites pairing UK Emergency Departments (ED) and ambulance services. At intervention sites, we recruited emergency healthcare practitioners to supply THN to patients presenting with opioid overdose or related condition, with recruitment across 2019–2021. We assessed feasibility of intervention implementation against four predetermined progression criteria covering site sign up and staff training; identification of eligible patients; issue of THN kits and Serious Adverse Events. At two intervention sites, randomly selected from 4, 299/687…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Prenatal Substance Exposure Effects
